Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

Core Viewpoint - Kiniksa Pharmaceuticals International will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025, highlighting its focus on therapeutic medicines for unmet medical needs [1]. Company Overview - Kiniksa is a commercial-stage biopharmaceutical company dedicated to discovering, acquiring, developing, and commercializing therapeutic medicines for patients with debilitating diseases [3]. - The company specializes in immune-modulating assets that target underserved cardiovascular and autoimmune conditions, aiming for differentiation based on strong biological rationale or validated mechanisms [3]. Event Details - The presentation will take place at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) [1]. - A live webcast of the presentation will be available on Kiniksa's website, with a replay accessible approximately 48 hours after the event [2].